Industry urges DoP to expedite implementation of PTUAS
Recommends changes in the existing criteria of PTUAS
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
MetP Pharma nasal gel to be evaluated for potential to prevent HRV-A16 infection
The results of the study are expected at the end of October 2020
Novavax commences Phase 2 clinical trial of COVID-19 vaccine candidate
Trial to enroll up to 1,500 volunteers in the US and Australia, with approximately 50 per cent between 60 and 84 years of age
West Pharma Services commences warehousing operations in Chennai
The warehouse will initially stock a small number of the top SKUs being ordered by customers from these regions and will expand to…
Common osteoporosis drugs can increase risk of rare fractures
The risk of atypical femur fractures increases with longer bisphosphonate use, especially after five years
FDA issues EUA to convalescent plasma for COVID–19 treatment
The FDA determined that it is reasonable to believe that COVID-19 convalescent plasma may be effective in lessening the severity…
Shilpa Medicare forays into the OTC segment
Launches Green T Film, a ready-to-drink product
USPTO grants patent to Tiziana for fully human monoclonal antibody, TZLS-501
The grant of this additional patent on TZLS-501 is of significance for the potential treatment of COVID-19 and other pulmonary…
Jubilant Life Sciences to focus on operational, financial performance in near-term
To tide over the COVID-19 pandemic led crisis, the company in the near-term is deferring its major CAPEX plans, informs annual…
China gives emergency authorisation for COVID-19 vaccines: Official
It has been previously reported that employees of state-owned enterprises preparing to go abroad and frontline medics have been…
Quality: How serious are we?
Alok Ghosh, Ex-President - Global Technical Operations, Lupin, informs that with increasing competition and price control, it is…
Panacea Biotec terminates MoU with Refana for COVID-19 vaccine
The company informed that the termination is due to delays in project timelines and difficulty in moving ahead with the joint…
Granules Pharma receives US FDA approval for Ramelteon tablets
They are used for the treatment of insomnia characterised by difficulty with sleep onset
ICMR developing portal for info on COVID-19 vaccine
The portal is likely to be functional by next week
Bharat Biotech gets green signal from CDSCO to test COVAXIN via skin
Presently, the vaccine is being tested through the intramuscular route
Remdesivir has only marginal benefit for moderate COVID-19 patients
The 600-patient analysis found that moderately-ill patients treated with Remdesivir for up to five days had significantly higher…
US pharma firm, Advanced Penetration Technology tests FDA-approved ointment to treat COVID-19
A research concludes that APT T3X effectively neutralises viral infectivity within seconds and its topical intranasal use can…
Roll-out plan of Sputnik-V prompts worries about virus mutation
Viruses are known for their ability to mutate all the time - and often this has little or no impact on the risk posed to people
40 per cent participants enrolled for COVID-19 vaccine trial: Moderna
Moderna began the study of its vaccine candidate, mRNA-1273, in July and expects to complete enrollment in September
DoP organises meeting with industry stakeholders on UCPMP implementation
Also discusses black marketing of COVID-19 treatment-related drugs in the country